254 related articles for article (PubMed ID: 24249742)
1. Bruton's tyrosine kinase--an integral protein of B cell development that also has an essential role in the innate immune system.
López-Herrera G; Vargas-Hernández A; González-Serrano ME; Berrón-Ruiz L; Rodríguez-Alba JC; Espinosa-Rosales F; Santos-Argumedo L
J Leukoc Biol; 2014 Feb; 95(2):243-50. PubMed ID: 24249742
[TBL] [Abstract][Full Text] [Related]
2. Consequences of two naturally occurring missense mutations in the structure and function of Bruton agammaglobulinemia tyrosine kinase.
Vargas-Hernández A; López-Herrera G; Maravillas-Montero JL; Vences-Catalán F; Mogica-Martínez D; Rojo-Domínguez A; Espinosa-Rosales FJ; Santos-Argumedo L
IUBMB Life; 2012 Apr; 64(4):346-53. PubMed ID: 22378381
[TBL] [Abstract][Full Text] [Related]
3. BTK Signaling in B Cell Differentiation and Autoimmunity.
Corneth OBJ; Klein Wolterink RGJ; Hendriks RW
Curr Top Microbiol Immunol; 2016; 393():67-105. PubMed ID: 26341110
[TBL] [Abstract][Full Text] [Related]
4. Bruton's tyrosine kinase controls a sustained calcium signal essential for B lineage development and function.
Rawlings DJ
Clin Immunol; 1999 Jun; 91(3):243-53. PubMed ID: 10370369
[TBL] [Abstract][Full Text] [Related]
5. Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes.
Pérez de Diego R; López-Granados E; Pozo M; Rodríguez C; Sabina P; Ferreira A; Fontan G; García-Rodríguez MC; Alemany S
J Allergy Clin Immunol; 2006 Jun; 117(6):1462-9. PubMed ID: 16751014
[TBL] [Abstract][Full Text] [Related]
6. Debilitating progressive encephalitis in a patient with BTK deficiency.
Mohammadzadeh I; Yeganeh M; Khaledi M; Salehiomran MR; Aghamohammadi A; Rezaei N
Acta Microbiol Immunol Hung; 2012 Sep; 59(3):335-42. PubMed ID: 22982637
[TBL] [Abstract][Full Text] [Related]
7. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages.
de Weers M; Verschuren MC; Kraakman ME; Mensink RG; Schuurman RK; van Dongen JJ; Hendriks RW
Eur J Immunol; 1993 Dec; 23(12):3109-14. PubMed ID: 8258324
[TBL] [Abstract][Full Text] [Related]
8. Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemia.
Brunner C; Kreth HW; Ochs HD; Schuster V
J Clin Immunol; 2002 Jul; 22(4):244-51. PubMed ID: 12148599
[TBL] [Abstract][Full Text] [Related]
9. Bruton's tyrosine kinase is activated upon CD40 stimulation in human B lymphocytes.
Brunner C; Avots A; Kreth HW; Serfling E; Schuster V
Immunobiology; 2002 Oct; 206(4):432-40. PubMed ID: 12437073
[TBL] [Abstract][Full Text] [Related]
10. Composition of precursor B-cell compartment in bone marrow from patients with X-linked agammaglobulinemia compared with healthy children.
Noordzij JG; de Bruin-Versteeg S; Comans-Bitter WM; Hartwig NG; Hendriks RW; de Groot R; van Dongen JJ
Pediatr Res; 2002 Feb; 51(2):159-68. PubMed ID: 11809909
[TBL] [Abstract][Full Text] [Related]
11. Bruton's tyrosine kinase is essential for human B cell tolerance.
Ng YS; Wardemann H; Chelnis J; Cunningham-Rundles C; Meffre E
J Exp Med; 2004 Oct; 200(7):927-34. PubMed ID: 15466623
[TBL] [Abstract][Full Text] [Related]
12. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells.
Smith CI; Baskin B; Humire-Greiff P; Zhou JN; Olsson PG; Maniar HS; Kjellén P; Lambris JD; Christensson B; Hammarström L
J Immunol; 1994 Jan; 152(2):557-65. PubMed ID: 8283037
[TBL] [Abstract][Full Text] [Related]
13. Genetic analysis of patients with defects in early B-cell development.
Conley ME; Broides A; Hernandez-Trujillo V; Howard V; Kanegane H; Miyawaki T; Shurtleff SA
Immunol Rev; 2005 Feb; 203():216-34. PubMed ID: 15661032
[TBL] [Abstract][Full Text] [Related]
14. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
Gaspar HB; Lester T; Levinsky RJ; Kinnon C
Clin Exp Immunol; 1998 Feb; 111(2):334-8. PubMed ID: 9486400
[TBL] [Abstract][Full Text] [Related]
15. The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective.
Satterthwaite AB; Witte ON
Immunol Rev; 2000 Jun; 175():120-7. PubMed ID: 10933597
[TBL] [Abstract][Full Text] [Related]
16. BTK mutations in patients with X-linked agammaglobulinemia: lack of correlation between presence of peripheral B lymphocytes and specific mutations.
Tao L; Boyd M; Gonye G; Malone B; Schwaber J
Hum Mutat; 2000 Dec; 16(6):528-9. PubMed ID: 11102984
[TBL] [Abstract][Full Text] [Related]
17. X-linked agammaglobulinemia in a 10-year-old boy with a novel non-invariant splice-site mutation in Btk gene.
Maekawa K; Yamada M; Okura Y; Sato Y; Yamada Y; Kawamura N; Ariga T
Blood Cells Mol Dis; 2010 Apr; 44(4):300-4. PubMed ID: 20122858
[TBL] [Abstract][Full Text] [Related]
18. X-Linked Agammagobulinemia in a Large Series of North African Patients: Frequency, Clinical Features and Novel BTK Mutations.
Aadam Z; Kechout N; Barakat A; Chan KW; Ben-Ali M; Ben-Mustapha I; Zidi F; Ailal F; Attal N; Doudou F; Abbadi MC; Kaddache C; Smati L; Touri N; Chemli J; Gargah T; Brini I; Bakhchane A; Charoute H; Jeddane L; El Atiqi S; El Hafidi N; Hida M; Saile R; Alj HS; Boukari R; Bejaoui M; Najib J; Barbouche MR; Lau YL; Mellouli F; Bousfiha AA
J Clin Immunol; 2016 Apr; 36(3):187-94. PubMed ID: 26931785
[TBL] [Abstract][Full Text] [Related]
19. A new mutation that predicted a drastic alteration of the BTK protein function.
Debost-Legrand A; Legrand G; Moulillot G; Francannet C; Bocly B; Theodoroub I; Paillard C
Gene; 2013 Sep; 527(1):426-8. PubMed ID: 23774691
[TBL] [Abstract][Full Text] [Related]
20. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement.
Petro JB; Rahman SM; Ballard DW; Khan WN
J Exp Med; 2000 May; 191(10):1745-54. PubMed ID: 10811867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
